Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis
暂无分享,去创建一个
Kristian Thorlund | Edward J Mills | Ping Wu | Eric Druyts | K. Thorlund | E. Mills | P. Goadsby | Ping Wu | Peter J Goadsby | E. Druyts | Elodie Ramos | Anjan Chatterjee | E. Ramos | A. Chatterjee
[1] J. Pascual,et al. Marketed Oral Triptans in the Acute Treatment of Migraine: A Systematic Review on Efficacy and Tolerability , 2007, Headache.
[2] R. Lipton,et al. Migraine--current understanding and treatment. , 2002, The New England journal of medicine.
[3] P. Tfelt-Hansen. A Review of Evidence-Based Medicine and Meta-Analytic Reviews in Migraine , 2006, Cephalalgia : an international journal of headache.
[4] P. Tfelt-Hansen. Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register , 2011, The Journal of Headache and Pain.
[5] A. May,et al. EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force , 2009, European journal of neurology.
[6] John Ioannidis,et al. Exploring the Geometry of Treatment Networks , 2008, Annals of Internal Medicine.
[7] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[8] A E Ades,et al. Meta‐analysis of mixed treatment comparisons at multiple follow‐up times , 2007, Statistics in medicine.
[9] J. Olesen,et al. Cost of disorders of the brain in Europe , 2005, European journal of neurology.
[10] Nicky J Welton,et al. Evaluating novel agent effects in multiple‐treatments meta‐regression , 2010, Statistics in medicine.
[11] R. Lipton,et al. Variation in migraine prevalence by race , 1996, Neurology.
[12] Kristian Thorlund,et al. How to use an article reporting a multiple treatment comparison meta-analysis. , 2012, JAMA.
[13] E. Loder,et al. Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators , 2012, Cephalalgia : an international journal of headache.
[14] Guobing Lu,et al. Modeling between-trial variance structure in mixed treatment comparisons. , 2009, Biostatistics.
[15] S. Silberstein,et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults , 2012, Neurology.
[16] T. Sprenger,et al. Current practice and future directions in the prevention and acute management of migraine , 2010, The Lancet Neurology.
[17] P. Goadsby. The pharmacology of headache , 2000, Progress in Neurobiology.
[18] Kristian Thorlund,et al. Multiple treatment comparison meta-analyses: a step forward into complexity , 2011, Clinical epidemiology.
[19] M. Stokes,et al. Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS) , 2011, Headache.
[20] J. Olesen. The International Classification of Headache Disorders , 2008, Headache.
[21] P. Tfelt-Hansen. Unpublished clinical trials with sumatriptan , 2009, The Lancet.
[22] W F Stewart,et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. , 1992, JAMA.
[23] H. Cramér. Mathematical methods of statistics , 1947 .
[24] R. Lipton,et al. Lost productive time and cost due to common pain conditions in the US workforce. , 2003, JAMA.
[25] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[26] P. Goadsby,et al. Diencephalic and brainstem mechanisms in migraine , 2011, Nature Reviews Neuroscience.
[27] R. Lipton,et al. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials , 2001, The Lancet.
[28] G. Lu,et al. Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.
[29] R. Lipton,et al. Migraine, quality of life, and depression , 2000, Neurology.